StemoniX (acquired by AxoSim)

StemoniX Friends | We are excited to announce that our neuroscience assets have been acquired by @AxoSim. Read Announcement: lnkd.in/g3gxnJxc. Follow @AxoSim for continued updates.  #drugdiscovery #neuroscience #organoids #pns #cns

In addition to microBrain™, @AxoSim has its NerveSim® platform, the first microphysiological system (MPS) of the peripheral nerve. Register for a webinar May 8th to learn more: #neuroscience #adcs #sarm1 #mps #webinar. lnkd.in/gh-Anw4W

Join Andrew LaCroix, Lead Scientist at AxoSim, alongside David Gallegos and Matt Wagoner from Takeda Pharmaceuticals, for a discussion about the value of microBrain™ Functional Organoids in neurotoxicity assessment. Register: buff.ly/3P26Bt0 #microbrain

Scientists Andrew LaCroix and Nicholas Coungeris are prepping to share with you the latest developments on the microBrain™ technology. Register for @AxoSim Dec 6th webinar today: lnkd.in/g7SXyzFp

The StemoniX human iPSC-derived neural platforms are ideal for disease modeling and toxicity screening. Visit our virtual booth at #SfN21 and connect with us at [email protected] to learn more!

Great energy at #SfN21! Excited to spend time catching up on the latest in #stemcell research! Stop by our virtual booth to learn how we can help you on your discovery journey. Let's connect! Visit our virutal booth and reach out to [email protected]

Love talking about our predictive human-first iPSC-derived platforms, high throughput screening, and toxicity research at #SfN21. Stop by our virtual booth to discuss your research needs! StemoniX.com

Good morning! Looking forward to another day at #SfN21 discussing stem cells, toxicity, and drug discovery! Join us! Contact [email protected] to set up a meeting!

We’re at #SfN21. Excited to discuss stem cells, #toxicity, and #drugdiscovery! Interested in learning more about how our human-first approach is de-risking drug discovery? Visit our virtual booth and contact us at [email protected]

Meet us online at #SfN21 and learn how the StemoniX team of experts are bringing human biology to the bench. Stop by our virtual booth to learn how we can help you in your toxicity and discovery research. [email protected]

Miss our poster due to #SfN21 technical difficulties? Learn more about our human-iPSC-derived platforms in neuro-based disease modeling, toxicity, and discovery research! Stop by our virtual booth or contact us at [email protected]! Find our poster here: ow.ly/6cHu50GIKNU

Having a great day at #SfN21! Stop by our virtual booth to learn how StemoniX is de-risking drug discovery or reach out at [email protected]!

Attending #SfN21? Stop by our virtual booth to learn more about how our consistent, predictive neural spheroids are de-risking drug discovery!

Looking forward to Virtual SfN 2021 next month! Interested in connecting? Contact us at [email protected]

We had a great time talking about our predictive human-first iPSC-derived platforms at the 2021 PREDiCT 3D conference. Looking forward to seeing you all in person next year! Visit StemoniX.com to learn more and contact us at [email protected]

Good morning from the PREDiCT 3D Tissue Models Summit! Looking forward to another great day discussing stem cells, toxicity, and drug discovery! Want to learn more? Contact [email protected] to set up a meeting!

We’re at the 2021 Virtual PREDiCT 3D conference. Excited to discuss stem cells, toxicity, and drug discovery! Interested in learning more about how our human-first approach is de-risking drug discovery? Contact us at [email protected]

Thrilled to be presenting at the 2021 Predict 3D conference next month. Looking forward to discussing how our high-throughput 3D platform brings a human-first approach to drug discovery! StemoniX.com

In this month’s blog, learn more about how StemoniX and vivoPharm are working together to take your drugs from ID to IND! ow.ly/iUvX50FHtze

Celebrating the issuance of our latest patent, “High Throughput Optical Assay of Human Mixed Cell Population Spheroids”! bit.ly/3B4rhrK